India · Delayed Price · Currency is INR Banka BioLoo Statistics
Total Valuation
Banka BioLoo has a market cap or net worth of INR 962.63 million. The enterprise value is 1.26 billion.
| Market Cap | 962.63M |
| Enterprise Value | 1.26B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Banka BioLoo has 10.85 million shares outstanding.
| Current Share Class | 10.85M |
| Shares Outstanding | 10.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 57.77% |
| Owned by Institutions (%) | n/a |
| Float | 4.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.84 |
| PB Ratio | 3.05 |
| P/TBV Ratio | 3.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.74 |
| EV / Sales | 2.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.81 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -6.47% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 471,910 |
| Profits Per Employee | -82,797 |
| Employee Count | 1,111 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -4.26M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.42% in the last 52 weeks. The beta is 0.54, so Banka BioLoo's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | -30.42% |
| 50-Day Moving Average | 82.94 |
| 200-Day Moving Average | 81.99 |
| Relative Strength Index (RSI) | 54.79 |
| Average Volume (20 Days) | 20,588 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Banka BioLoo had revenue of INR 524.29 million and -91.99 million in losses.
| Revenue | 524.29M |
| Gross Profit | 88.80M |
| Operating Income | -68.29M |
| Pretax Income | -96.25M |
| Net Income | -91.99M |
| EBITDA | -40.70M |
| EBIT | -68.29M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 46.49 million in cash and 347.28 million in debt, giving a net cash position of -300.79 million or -27.73 per share.
| Cash & Cash Equivalents | 46.49M |
| Total Debt | 347.28M |
| Net Cash | -300.79M |
| Net Cash Per Share | -27.73 |
| Equity (Book Value) | 315.85M |
| Book Value Per Share | 29.26 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 16.94%, with operating and profit margins of -13.03% and -17.54%.
| Gross Margin | 16.94% |
| Operating Margin | -13.03% |
| Pretax Margin | -18.36% |
| Profit Margin | -17.54% |
| EBITDA Margin | -7.76% |
| EBIT Margin | -13.03% |
| FCF Margin | n/a |
Dividends & Yields
Banka BioLoo does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -9.56% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 8, 2020. It was a forward split with a ratio of 2.5.
| Last Split Date | Sep 8, 2020 |
| Split Type | Forward |
| Split Ratio | 2.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |